Food and Drug Administration

Cellular, Tissue and Gene Therapies Advisory Committee

September 29, 2005


Vision and Overview, Jesse Goodman, MD MPH, FDA (HTM) (PPT)

FDA's Critical Path Research Initiative & Intro to the CBER Research Program, Kathryn Carbone, MD, FDA (HTM) (PPT)

Cellular Tissue and Gene Therapies Research Site Visit, Celia Witten, PhD, MD, FDA (HTM) (PPT)

Division of Cellular and Gene Therapies (DCGT), Raj Puri, MD, PhD, FDA (HTM)(PPT)

Research Management, Priorities, and Accompilshments, Suzanne Epstein, PhD, FDA (HTM) (PPT)